{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:05:50Z","timestamp":1789189550431,"version":"build-2803163510"},"reference-count":133,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Ferroptosis is a regulated form of cell death caused by iron-dependent membrane lipid peroxidation. Iron metabolism, membrane lipid composition, cellular metabolic pathways, and antioxidant defense systems regulate ferroptosis. Recently, ferroptosis has attracted interest as a target in cancer therapy, in particular cancer cells have developed several biological adaptative mechanisms to evade ferroptosis, thus enhancing tumor progression, metastatic dissemination, stemness, and resistance to conventional therapies. Interestingly, ferroptosis is regulated by the tumor microenvironment, where hypoxia, immune cells, and stromal components can either stimulate or inhibit ferroptotic cell death. It has been demonstrated that targeting ferroptosis, alone or in combination with chemotherapy, radiotherapy and immunotherapy, has anticancer effects in preclinical models and may contribute to avoid treatment resistance. However, the role of ferroptosis in pediatric cancer remains incompletely understood since these kinds of tumors show different developmental, genomic, and metabolic features that may contribute to create different ferroptosis vulnerabilities. Emerging evidence in neuroblastoma, B-cell acute lymphoblastic leukemia, osteosarcoma, and medulloblastoma supports the involvement of ferroptosis-related pathways in tumor biology and treatment response. Preclinical studies also indicate that ferroptosis induction may represent a therapeutic strategy in selected pediatric cancer models, although tumor heterogeneity, drug delivery, and potential toxicity to developing tissues remain important translational challenges. This review summarizes the molecular mechanisms underlining the relationship between ferroptosis and cancer biology, tumor progression, tumor microenvironment, and therapy resistance, with particular interest in its emerging relevance and therapeutic potential in pediatric oncology, while critically considering the current evidence and major challenges for clinical translation.<\/jats:p>","DOI":"10.3390\/ijms27188067","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:04:57Z","timestamp":1789045497000},"page":"8067","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Emerging Role of Ferroptosis in Pediatric Cancer Biology and Therapy"],"prefix":"10.3390","volume":"27","author":[{"given":"Alessandra","family":"Di Paola","sequence":"first","affiliation":[{"name":"Department of Life Science, Health and Health Professions, Link Campus University, 00165 Rome, Italy"},{"name":"Department of Woman, Child and General and Specialist Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Maddalena","family":"Marrapodi","sequence":"additional","affiliation":[{"name":"Department of Woman, Child and General and Specialist Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Feo","sequence":"additional","affiliation":[{"name":"Department of Woman, Child and General and Specialist Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Di Martino","sequence":"additional","affiliation":[{"name":"Department of Woman, Child and General and Specialist Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9396-2906","authenticated-orcid":false,"given":"Daniela","family":"Di Pinto","sequence":"additional","affiliation":[{"name":"Department of Woman, Child and General and Specialist Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2530-3267","authenticated-orcid":false,"given":"Lucia","family":"Argenziano","sequence":"additional","affiliation":[{"name":"Department of Woman, Child and General and Specialist Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Di Domenico","sequence":"additional","affiliation":[{"name":"Department of Woman, Child and General and Specialist Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Rossi","sequence":"additional","affiliation":[{"name":"Department of Woman, Child and General and Specialist Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Pota","sequence":"additional","affiliation":[{"name":"Department of Woman, Child and General and Specialist Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41420-024-01825-7","article-title":"Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation","volume":"10","author":"Jin","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","article-title":"Ferroptosis: Principles and significance in health and disease","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","article-title":"Exploiting ferroptosis vulnerabilities in cancer","volume":"26","author":"Nakamura","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Neophytou, C.M., and Trougakos, I.P. (2021). Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. Cancers, 13.","DOI":"10.3390\/cancers13174363"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"102773","DOI":"10.1016\/j.ctrv.2024.102773","article-title":"Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck","volume":"129","author":"Skinner","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12943-025-02520-6","article-title":"Ferroptosis in cancer: Metabolism, mechanisms and therapeutic prospects","volume":"24","author":"Wu","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"D\u2019Amico, M., and De Amicis, F. (2024). Challenges of Regulated Cell Death: Implications for Therapy Resistance in Cancer. Cells, 13.","DOI":"10.3390\/cells13131083"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4062\/biomolther.2025.211","article-title":"Targeting Ferroptosis to Overcome Drug Resistance in Cancer: Molecular Mechanisms and Therapeutic Prospects","volume":"34","author":"Joo","year":"2026","journal-title":"Biomol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","article-title":"Targeting ferroptosis opens new avenues for the development of novel therapeutics","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chi, H., Li, B., Wang, Q., Gao, Z., Feng, B., Xue, H., and Li, G. (2023). Opportunities and challenges related to ferroptosis in glioma and neuroblastoma. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1065994"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1007\/s12035-024-04501-0","article-title":"Pharmacologically Targeting Ferroptosis and Cuproptosis in Neuroblastoma","volume":"62","author":"Liu","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41568-024-00710-w","article-title":"Developmental origins shape the paediatric cancer genome","volume":"24","author":"Chen","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41389-026-00617-1","article-title":"Reprogramming lipid metabolism in pediatric cancers","volume":"15","author":"Lindemann","year":"2026","journal-title":"Oncogenesis"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1126\/science.aaw3535","article-title":"The genomic landscape of pediatric cancers: Implications for diagnosis and treatment","volume":"363","author":"Biegel","year":"2019","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Dushimova, Z., and Saliev, T. (2026). Optimizing the Efficacy-Toxicity Paradigm in Pediatric Oncology: A Narrative Review of Immunotherapy and Survivorship Outcomes. Curr. Oncol., 33.","DOI":"10.3390\/curroncol33050298"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Rossi, F., Di Paola, A., Pota, E., Argenziano, M., Di Pinto, D., Marrapodi, M.M., Di Leva, C., Di Martino, M., and Tortora, C. (2021). Biological Aspects of Inflamm-Aging in Childhood Cancer Survivors. Cancers, 13.","DOI":"10.3390\/cancers13194933"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Han, J., Yang, Y., Wei, Y., Jin, J., and Feng, W. (2025). Ferroptosis: A new dawn in the treatment of acute lymphoblastic leukemia. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1669432"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Liu, Z., Ma, Z., Yang, K., and Fan, H. (2026). Ferroptosis in Glioblastoma and Neuroblastoma: Molecular Mechanisms and Novel Therapeutic Strategies. Curr. Issues Mol. Biol., 48.","DOI":"10.3390\/cimb48030267"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/path.6245","article-title":"FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis","volume":"262","author":"Zhou","year":"2024","journal-title":"J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41698-025-01090-6","article-title":"Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma","volume":"9","author":"Seger","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/0008-5472.CAN-20-1641","article-title":"MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-\/Glutathione Axis","volume":"81","author":"Floros","year":"2021","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41419-021-03790-w","article-title":"MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma","volume":"12","author":"Lu","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s43018-022-00355-4","article-title":"MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis","volume":"3","author":"Alborzinia","year":"2022","journal-title":"Nat. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13073-026-01622-0","article-title":"Spatial multi-omics characterization of neuroblastoma reveals ferroptosis-associated metabolic features in high-risk tumors","volume":"18","author":"Tu","year":"2026","journal-title":"Genome Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Li, X., Wang, Q., Xu, C., Zhang, L., Zhou, J., Lv, J., Xu, M., and Jiang, D. (2023). Ferroptosis Inducers Kill Mesenchymal Stem Cells Affected by Neuroblastoma. Cancers, 15.","DOI":"10.3390\/cancers15041301"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Valenti, G.E., Roveri, A., Venerando, R., Menichini, P., Monti, P., Tasso, B., Traverso, N., Domenicotti, C., and Marengo, B. (2023). PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis. Antioxidants, 13.","DOI":"10.3390\/antiox13010003"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41418-025-01623-3","article-title":"Dual lipid modulation overcomes ferroptosis resistance in high-risk neuroblastoma","volume":"33","author":"Koeken","year":"2026","journal-title":"Cell Death Differ."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Anthonydhason, V., Islamagic, E., Leijon, N., Gaarder, J., Martinsson, T., Fransson, S., Thor\u00e9n, F.B., and Umapathy, G. (2026). Erastin-induced ferroptosis enhances natural killer cell anti-tumor activity and offers therapeutic potential in neuroblastoma. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1739503"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/cbin.11121","article-title":"The induction of ferroptosis by impairing STAT3\/Nrf2\/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin","volume":"43","author":"Liu","year":"2019","journal-title":"Cell Biol. Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1038\/s41467-025-59531-6","article-title":"CREBBP inactivation sensitizes B cell acute lymphoblastic leukemia to ferroptotic cell death upon BCL2 inhibition","volume":"16","author":"Ditcham","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: Mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Piccolo, M., and Ferraro, M.G. (2024). Insight into Iron, Oxidative Stress and Ferroptosis: Therapy Targets for Approaching Anticancer Strategies. Cancers, 16.","DOI":"10.3390\/cancers16061220"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Rochette, L., Dogon, G., Rigal, E., and Zeller, M. (2022). Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010449"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zhang, X.D., Liu, Z.Y., Wang, M.S., Guo, Y.X., Wang, X.K., Luo, K., Huang, S., and Li, R.F. (2023). Mechanisms and regulations of ferroptosis. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1269451"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cub.2023.02.060","article-title":"Lipid peroxidation increases membrane tension, Piezo1 gating, and cation permeability to execute ferroptosis","volume":"33","author":"Hirata","year":"2023","journal-title":"Curr. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41418-020-00691-x","article-title":"Ferroptotic pores induce Ca2+ fluxes and ESCRT-III activation to modulate cell death kinetics","volume":"28","author":"Pedrera","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41556-020-0565-1","article-title":"Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture","volume":"22","author":"Riegman","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","article-title":"Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer","volume":"22","author":"Liu","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","article-title":"Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers","volume":"16","author":"Soula","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP Cyclohydrolase 1\/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"103211","DOI":"10.1016\/j.redox.2024.103211","article-title":"Ferroptosis in health and disease","volume":"75","author":"Berndt","year":"2024","journal-title":"Redox Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"106094","DOI":"10.1016\/j.biocel.2021.106094","article-title":"Cancer: The role of iron and ferroptosis","volume":"141","author":"Rishi","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00018-025-05982-5","article-title":"Ferroptosis and cancer: When iron turns against tumors","volume":"83","author":"Toyokuni","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","article-title":"p53 in ferroptosis regulation: The new weapon for the old guardian","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1038\/s41388-021-01790-w","article-title":"Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity","volume":"40","author":"Lei","year":"2021","journal-title":"Oncogene"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1101\/gad.275891.115","article-title":"An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model","volume":"30","author":"Jennis","year":"2016","journal-title":"Genes Dev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.celrep.2016.09.022","article-title":"Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression","volume":"17","author":"Wang","year":"2016","journal-title":"Cell Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jtho.2022.03.011","article-title":"KEAP1-Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting Hub","volume":"17","author":"Scalera","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","article-title":"A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers","volume":"13","author":"Koppula","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"eabj9141","DOI":"10.1126\/sciadv.abj9141","article-title":"MLL4 mediates differentiation and tumor suppression through ferroptosis","volume":"7","author":"Egolf","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Zhu, K., Cai, Y., Lan, L., and Luo, N. (2024). Tumor Metabolic Reprogramming and Ferroptosis: The Impact of Glucose, Protein, and Lipid Metabolism. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413413"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/cac2.12519","article-title":"Cellular metabolism: A key player in cancer ferroptosis","volume":"44","author":"Jiang","year":"2024","journal-title":"Cancer Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.tcb.2020.03.002","article-title":"The Complex Interplay between Antioxidants and ROS in Cancer","volume":"30","author":"Harris","year":"2020","journal-title":"Trends Cell Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/0008-5472.CAN-21-3914","article-title":"GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma","volume":"82","author":"Suzuki","year":"2022","journal-title":"Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/0008-5472.CAN-13-0382-T","article-title":"An essential requirement for the SCAP\/SREBP signaling axis to protect cancer cells from lipotoxicity","volume":"73","author":"Williams","year":"2013","journal-title":"Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9653244","DOI":"10.1155\/2022\/9653244","article-title":"Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting","volume":"2022","author":"Bisht","year":"2022","journal-title":"Stem Cells Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer stem cells: Advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"101678","DOI":"10.1016\/j.gendis.2025.101678","article-title":"Targeting ferroptosis in cancer stem cells: A novel strategy to improve cancer treatment","volume":"12","author":"Wang","year":"2025","journal-title":"Genes Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"105450","DOI":"10.1016\/j.ejps.2020.105450","article-title":"Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis","volume":"152","author":"Xu","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e1028","DOI":"10.1002\/ctm2.1028","article-title":"Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression","volume":"12","author":"Zhu","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: A hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-025-02544-y","article-title":"Ferroptosis and metastasis: Molecular checkpoints, microenvironmental dynamics, and therapeutic opportunities","volume":"25","author":"Guo","year":"2026","journal-title":"Mol. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","article-title":"Ferroptosis and the tumor microenvironment","volume":"43","author":"Cui","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zheng, X., Liang, Y., and Zhang, C. (2023). Ferroptosis Regulated by Hypoxia in Cells. Cells, 12.","DOI":"10.3390\/cells12071050"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12672-024-01573-1","article-title":"Current advances on the role of ferroptosis in tumor immune evasion","volume":"15","author":"Gao","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","article-title":"Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death","volume":"16","author":"Kapralov","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1080\/15548627.2020.1714209","article-title":"Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein","volume":"16","author":"Dai","year":"2020","journal-title":"Autophagy"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41420-024-01958-9","article-title":"Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: Insights into apoptosis, autophagy, ferroptosis, and pyroptosis","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40164-025-00688-7","article-title":"Tumor-associated mesenchymal stem\/stromal cells in tumor microenvironment and carcinogenesis","volume":"14","author":"Sun","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","article-title":"CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"100960","DOI":"10.1016\/j.drup.2023.100960","article-title":"Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs","volume":"68","author":"Qi","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"C1039","DOI":"10.1152\/ajpcell.00454.2022","article-title":"Cancer-associated fibroblasts suppressed ferroptosis in glioblastoma via upregulating lncRNA DLEU1","volume":"324","author":"Zhao","year":"2023","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"100936","DOI":"10.1016\/j.drup.2023.100936","article-title":"Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer","volume":"68","author":"Qu","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"ref_95","first-page":"47","article-title":"Mechanism of ferroptosis resistance in cancer cells","volume":"7","author":"Wang","year":"2024","journal-title":"Cancer Drug Resist."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20517\/cdr.2024.151","article-title":"Ferroptosis-related signaling pathways in cancer drug resistance","volume":"8","author":"Yang","year":"2025","journal-title":"Cancer Drug Resist."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"102952","DOI":"10.1016\/j.redox.2023.102952","article-title":"RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer","volume":"68","author":"Xu","year":"2023","journal-title":"Redox Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11658-021-00271-y","article-title":"Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2\/Keap1\/xCT signaling","volume":"26","author":"Fu","year":"2021","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.freeradbiomed.2018.10.426","article-title":"Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer","volume":"129","author":"Shin","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"167210","DOI":"10.1016\/j.bbadis.2024.167210","article-title":"Ketogenesis attenuated KLF5 disrupts iron homeostasis via LIF to confer oxaliplatin vulnerability in colorectal cancer","volume":"1870","author":"Jiang","year":"2024","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.7150\/thno.46903","article-title":"Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis","volume":"10","author":"Lee","year":"2020","journal-title":"Theranostics"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Zhou, Q., Wang, X., Zhang, Y., Wang, L., and Chen, Z. (2022). Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis. BMC Oral Health, 22.","DOI":"10.1186\/s12903-022-02503-9"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e2301088","DOI":"10.1002\/advs.202301088","article-title":"Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer","volume":"10","author":"Zeng","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"102006","DOI":"10.1016\/j.redox.2021.102006","article-title":"Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence","volume":"43","author":"Luis","year":"2021","journal-title":"Redox Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12938-024-01288-y","article-title":"Ferroptosis in radiation-induced brain injury: Roles and clinical implications","volume":"23","author":"Li","year":"2024","journal-title":"Biomed. Eng. Online"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"101181","DOI":"10.1016\/j.spen.2025.101181","article-title":"Neurological sequalae in pediatric patients with CNS tumors after radiation treatment: A comprehensive review","volume":"53","author":"Kumar","year":"2025","journal-title":"Semin. Pediatr. Neurol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"101032","DOI":"10.1016\/j.drup.2023.101032","article-title":"Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance","volume":"73","author":"Lin","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e139434","DOI":"10.1172\/JCI139434","article-title":"TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis","volume":"131","author":"Jiang","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_109","first-page":"61","article-title":"BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition","volume":"10","author":"Meng","year":"2023","journal-title":"Mil. Med. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","article-title":"Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","article-title":"Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles","volume":"16","author":"Eaton","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.bmcl.2011.09.047","article-title":"Development of small-molecule probes that selectively kill cells induced to express mutant RAS","volume":"22","author":"Bittker","year":"2012","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"ref_118","first-page":"100939","article-title":"Recent progress of ferroptosis in cancers and drug discovery","volume":"19","author":"Wang","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Zhu, J., Shen, P., Xu, Y., Zhang, X., Chen, Q., Gu, K., Ji, S., Yang, B., and Zhao, Y. (2024). Ferroptosis: A new mechanism of traditional Chinese medicine for cancer treatment. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1290120"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"154682","DOI":"10.1016\/j.phymed.2023.154682","article-title":"Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy","volume":"112","author":"Han","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e70488","DOI":"10.1096\/fj.202403160R","article-title":"Artesunate induces ferroptosis in osteosarcoma through NCOA4-mediated ferritinophagy","volume":"39","author":"Huang","year":"2025","journal-title":"FASEB J."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41401-024-01258-z","article-title":"Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2\/STAT3\/GPX4 axis","volume":"45","author":"Lai","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e70010","DOI":"10.1002\/mco2.70010","article-title":"Ferroptosis: Mechanisms and therapeutic targets","volume":"5","author":"Zhou","year":"2024","journal-title":"MedComm"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Wang, X., Yang, J., Bian, H., and Yang, H. (2023). Development of A novel ferroptosis-related prognostic signature with multiple significance in paediatric neuroblastoma. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1067187"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e70921","DOI":"10.1002\/mco2.70921","article-title":"Ferroptosis: Newly Emerged Regulator for Human Disease","volume":"7","author":"Xiao","year":"2026","journal-title":"MedComm"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"114303","DOI":"10.1016\/j.addr.2022.114303","article-title":"Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors\u2014An update","volume":"185","author":"Power","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Gao, Q., Song, D., Xu, D., Chai, X., and Ge, M. (2025). Characteristics of the blood-brain barrier in pediatric brain tumors. Front. Pediatr., 13.","DOI":"10.3389\/fped.2025.1646641"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00381-025-07121-8","article-title":"Protocols and safety profile of convection enhanced delivery in pediatric patients: A systematic review","volume":"42","author":"Fredricks","year":"2026","journal-title":"Childs Nerv. Syst."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Rahman, R., Janowski, M., Killick-Cole, C.L., Singleton, W.G.B., Campbell, E., Walczak, P., Khatua, S., Faltings, L., Symons, M., and Schneider, J.R. (2023). Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials. Cancers, 15.","DOI":"10.3390\/cancers15030857"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41583-025-00930-5","article-title":"Neuroferroptosis in health and diseases","volume":"26","author":"Lei","year":"2025","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pediatrneurol.2024.03.031","article-title":"How Cancer Harms the Developing Brain: Long-Term Outcomes in Pediatric Cancer Survivors","volume":"156","author":"Siegel","year":"2024","journal-title":"Pediatr. Neurol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41419-024-06667-w","article-title":"Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells","volume":"15","author":"Ascenzi","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.trecan.2024.03.004","article-title":"Exploiting the metabolic vulnerability of circulating tumour cells","volume":"10","author":"Merteroglu","year":"2024","journal-title":"Trends Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8067\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:10:44Z","timestamp":1789186244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":133,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27188067"],"URL":"https:\/\/doi.org\/10.3390\/ijms27188067","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}